OpenLegislation

Paragraph 1 F1

In this Schedule—

  • “converted EU marketing authorisation” means an EU marketing authorisation to which paragraph 2 applies;

  • “EU marketing authorisation” means a marketing authorisation for a veterinary medicinal product granted by the European Commission in accordance with Title 3 of Regulation (EC) No 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.

Annotations

Textual amendments

F1

Sch. 1A inserted (E.W.S.) (31.12.2020) by The Food and Drink, Veterinary Medicines and Residues (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/865), regs. 1(2), 17(3), Sch. 8 Pt. 1; 2020 c. 1, Sch. 5 para. 1(1)